These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma. Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193 [TBL] [Abstract][Full Text] [Related]
43. Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN. Teitz T; Wei T; Liu D; Valentine V; Valentine M; Grenet J; Lahti JM; Kidd VJ Oncogene; 2002 Mar; 21(12):1848-58. PubMed ID: 11896617 [TBL] [Abstract][Full Text] [Related]
44. Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Maris JM; Guo C; Blake D; White PS; Hogarty MD; Thompson PM; Rajalingam V; Gerbing R; Stram DO; Matthay KK; Seeger RC; Brodeur GM Med Pediatr Oncol; 2001 Jan; 36(1):32-6. PubMed ID: 11464900 [TBL] [Abstract][Full Text] [Related]
45. Sublocalization of putative tumor suppressor gene loci on chromosome arm 14q in neuroblastoma. Theobald M; Christiansen H; Schmidt A; Melekian B; Wolkewitz N; Christiansen NM; Brinkschmidt C; Berthold F; Lampert F Genes Chromosomes Cancer; 1999 Sep; 26(1):40-6. PubMed ID: 10441004 [TBL] [Abstract][Full Text] [Related]
46. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1. Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803 [TBL] [Abstract][Full Text] [Related]
47. Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma. Srivatsan ES; Murali V; Seeger RC Prog Clin Biol Res; 1991; 366():91-8. PubMed ID: 2068183 [TBL] [Abstract][Full Text] [Related]
48. Deletion mapping of chromosome 1p and 22q in pheochromocytoma. Shin E; Fujita S; Takami K; Kurahashi H; Kurita Y; Kobayashi T; Mori T; Nishisho I; Takai S Jpn J Cancer Res; 1993 Apr; 84(4):402-8. PubMed ID: 8514606 [TBL] [Abstract][Full Text] [Related]
49. Detailed molecular analysis of 1p36 in neuroblastoma. White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901 [TBL] [Abstract][Full Text] [Related]
50. Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma. Komuro H; Valentine MB; Rowe ST; Kidd VJ; Makino S; Brodeur GM; Cohn SL; Look AT J Pediatr Surg; 1998 Nov; 33(11):1695-8. PubMed ID: 9856898 [TBL] [Abstract][Full Text] [Related]
51. [Demonstration of two regions involved in chromosome 1p deletion in breast tumors]. Bièche I; Champème MH; Matifas F; Cropp C; Callahan R; Lidereau R Bull Cancer; 1994 Feb; 81(2):108-13. PubMed ID: 7894115 [TBL] [Abstract][Full Text] [Related]
52. Loss of heterozygosity for chromosome 14q in neuroblastoma. Thompson PM; Seifried BA; Kyemba SK; Jensen SJ; Guo C; Maris JM; Brodeur GM; Stram DO; Seeger RC; Gerbing R; Matthay KK; Matise TC; White PS Med Pediatr Oncol; 2001 Jan; 36(1):28-31. PubMed ID: 11464899 [TBL] [Abstract][Full Text] [Related]
53. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190 [TBL] [Abstract][Full Text] [Related]
54. Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Srivatsan ES; Ying KL; Seeger RC Genes Chromosomes Cancer; 1993 May; 7(1):32-7. PubMed ID: 7688553 [TBL] [Abstract][Full Text] [Related]
55. Loss of heterozygosity for chromosome 1p in familial neuroblastoma. Tonini GP; Lo Cunsolo C; Cusano R; Iolascon A; Dagnino M; Conte M; Milanaccio C; De Bernardi B; Mazzocco K; Scaruffi P Eur J Cancer; 1997 Oct; 33(12):1953-6. PubMed ID: 9516831 [TBL] [Abstract][Full Text] [Related]
56. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. Bown N; Cotterill S; Lastowska M; O'Neill S; Pearson AD; Plantaz D; Meddeb M; Danglot G; Brinkschmidt C; Christiansen H; Laureys G; Speleman F; Nicholson J; Bernheim A; Betts DR; Vandesompele J; Van Roy N N Engl J Med; 1999 Jun; 340(25):1954-61. PubMed ID: 10379019 [TBL] [Abstract][Full Text] [Related]
57. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780 [TBL] [Abstract][Full Text] [Related]
58. Chromosome 1p and 11q deletions and outcome in neuroblastoma. Attiyeh EF; London WB; Mossé YP; Wang Q; Winter C; Khazi D; McGrady PW; Seeger RC; Look AT; Shimada H; Brodeur GM; Cohn SL; Matthay KK; Maris JM; N Engl J Med; 2005 Nov; 353(21):2243-53. PubMed ID: 16306521 [TBL] [Abstract][Full Text] [Related]
59. Restriction fragment length polymorphism analysis reveals different allele frequency and a linkage disequilibrium at locus D1S94 in neuroblastoma patients. Perri P; Pession A; Mazzocco K; Scaruffi P; Strigini P; Iolascon A; Albergoni MP; Basso G; Tonini GP Eur J Cancer; 1997 Oct; 33(12):1949-52. PubMed ID: 9516830 [TBL] [Abstract][Full Text] [Related]
60. Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas. Hogarty MD; Liu X; Guo C; Thompson PM; Weiss MJ; White PS; Sulman EP; Brodeur GM; Maris JM Med Pediatr Oncol; 2000 Dec; 35(6):512-5. PubMed ID: 11107105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]